All terms in HP
| Label | Id | Description |
|---|---|---|
| Proboscis | HP_0012806 | [A fleshy, tube-like structure usually located in the midline of the face or just to one side of the midline.] |
| Iris transillumination defect | HP_0012805 | [Transmission of light through the iris as visualized upon slit lamp examination or infrared iris transillumination videography. The light passes through defects in the pigmentation of the iris.] |
| menadione | CHEBI_28869 | [A member of the class of 1,4-naphthoquinones that is 1,4-naphthoquinone which is substituted at position 2 by a methyl group. It is used as a nutritional supplement and for the treatment of hypoprothrombinemia.] |
| 1,4-naphthoquinones | CHEBI_132142 | [A naphthoquinone in which the oxo groups of the quinone moiety are at positions 1 and 4 of the parent naphthalene ring.] |
| Corneal ulceration | HP_0012804 | [Disruption of the epithelial layer of the cornea with involvement of the underlying stroma.] |
| fatty acid | CHEBI_35366 | [Any aliphatic monocarboxylic acid derived from or contained in esterified form in an animal or vegetable fat, oil or wax.] |
| Hypoparathyroidism | HP_0000829 | [A condition caused by a deficiency of parathyroid hormone characterized by hypocalcemia and hyperphosphatemia.] |
| Abnormality of the parathyroid physiology | HP_0011767 | [A functional abnormality of the parathyroid gland.] |
| Hyperinsulinemic hypoglycemia | HP_0000825 | [An increased concentration of insulin combined with a decreased concentration of glucose in the blood.] |
| Hyperinsulinemia | HP_0000842 | [An increased concentration of insulin in the blood.] |
| Abnormality of the parathyroid gland | HP_0000828 | [An abnormality of the parathyroid gland.] |
| Hypothyroidism | HP_0000821 | [Deficiency of thyroid hormone.] |
| Growth delay | HP_0001510 | [A deficiency or slowing down of growth pre- and postnatally.] |
| Growth hormone deficiency | HP_0000824 | [Insufficient production of growth hormone, which is produced by the anterior pituitary gland. Growth hormone is a major participant in control of growth and metabolism.] |
| Anterior hypopituitarism | HP_0000830 | [A condition of reduced function of the anterior pituitary gland characterized by decreased secretion of one or more of the pituitary hormones growth hormone, thyroid-stimulating hormone, adrenocorticotropic hormone, prolactin, luteinizing hormone, and follicle-stimulating hormone.] |
| Abnormal growth hormone level | HP_0032367 | [Any deviation from the normal level of growth hormone (GH) in the blood circulation. GH or somatotropin is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration. Its secretion from the pituitary is regulated by the neurosecretory nuclei of the hypothalamus, which can release Growth hormone-releasing hormone (GHRH or somatocrinin) and Growth hormone-inhibiting hormone (GHIH or somatostatin) into the hypophyseal portal venous blood surrounding the pituitary. GH is secreted in a pulsatile manner, which is one of the reasons why an isolated measurement of its blood concentration is not meaningful.] |
| Hypopituitarism | HP_0040075 | |
| Insulin-resistant diabetes mellitus | HP_0000831 | [A type of diabetes mellitus related not to lack of insulin but rather to lack of response to insulin on the part of the target tissues of insulin such as muscle, fat, and liver cells. This type of diabetes is typically associated with increases both in blood glucose concentrations as will as in fasting and postprandial serum insulin levels.] |
| Insulin resistance | HP_0000855 | [Increased resistance towards insulin, that is, diminished effectiveness of insulin in reducing blood glucose levels.] |
| Myocarditis | HP_0012819 | [Inflammation of the myocardium.] |